U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. International Programs
  3. International Arrangements
  4. Cooperative Arrangements
  5. Confidentiality Commitments
  6. Update on Confidentiality Commitment with WHO’s Access to Medicines and Health Product Division (WHO/EMP)
  1. Confidentiality Commitments

Update on Confidentiality Commitment with WHO’s Access to Medicines and Health Product Division (WHO/EMP)

WHO’s Access to Medicines and Health Product Division (WHO/EMP) confirms that all activities and functions within the scope of WHO’s Department of Essential Medicines and Health Products (WHO/EMP) are now carried out by departments and units within WHO’s Access to Medicines and Health Products Division (MHP). This division is not a new entity or separate organization but a restructured office that remains part of WHO. WHO/MHP confirms that WHO/MHP is bound by the commitments made by WHO/EMP to protect FDA-provided non-public information in the existing arrangement and that WHO/EMP will continue to protect any non-public information previously shared.

Back to Top